Lou Portero

Urban Health Today

A recent study highlighted during the European Society for Medical Oncology (ESMO) 2021 meeting,&nbsp;showed that&nbsp;immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors were reported more frequently in females than in males. According to the study, the likely drivers for the disparity between sexes in irAEs are the well-documented biological differences in&nbsp;a&nbsp;woman&rsquo;s&nbsp;immune system reactions, with women tending to have stronger immune responses than men, regardless of age and ethnicity.The multi-center prospective study is conducted&nbsp;by&nbsp;the&nbsp;Fondazione IRCCS&nbsp;Istituto&nbsp;Nazionale&nbsp;dei&nbsp;Tumori, Milan, Italy;&nbsp;Karolinska University Hospital,&nbsp;Solna, Sweden;&nbsp;St Vincent&rsquo;s University Hospital,&nbsp;Dublin,&nbsp;Ireland;&nbsp;and&nbsp;Oslo University Hospital, Norway&nbsp;and is scheduled to conclude in 2023.The study also reveals that the initial results are encouraging for personalizing immunotherapy. &ldquo;The results are a more general indication that immunotherapy selection in the future should take into account not only the type of cancer but also the sex of the patient,&rdquo; said Dr. Berna &Ouml;zdemir, a member of the ESMO Gender Medicine Task Force. &ldquo;Women may benefit more from other agents that modulate the immune system, alone or in combination with other therapies, whereas men appear to respond better than women to the current checkpoint inhibitors.&rdquo;Results of this data demonstrate the need to redesign clinical trials to factor in patient sex and gender differences.Source &ndash; 
https://dailyreporter.esmo.org/esmo-congress-2021/translational-research/women-receiving-immunotherapy-may-be-at-higher-risk-of-adverse-events-than-men

Payton White, BS

How Sleep Quality Influences Risk of Alzheimer’s Disease

Alzheimer's & Dementia

Hidden Dangers: The Blood Sugar Crisis in Modern Breast Cancer Treatment

Diabetes in Women

New ACG Guidelines Address Critical Gastric Cancer Disparities in Non-White Americans

Gastroenterology

Latest News

Women May Have Higher Risk Than Men of Adverse Effects From Immunotherapy

Cancer

A recent study highlighted during the European Society for Medical Oncology (ESMO) 2021 meeting, showed ...

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Diabetes

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe